Vertex Pharmaceuticals Inc / Ma
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 364,400 | 0.3% | 803,773 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 525,373 | 0.5% | 1,341,470 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 536,820 | 0.6% | 1,205,796 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 465,841 | 0.5% | 960,854 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 390,886 | 0.4% | 970,662 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 482,403 | 0.5% | 1,037,248 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 511,510 | 0.6% | 1,091,299 | 6/30/2024 |
| 2024 Q1 | 5/15/2024 | 125,181 | 0.1% | 299,471 | 3/31/2024 |
| 2023 Q4 | 2/16/2024 | 118,289 | 0.2% | 290,715 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 74,893 | 0.1% | 215,370 | 9/30/2023 |
| 2023 Q2 | 5/17/2024 | 62,180 | 0.1% | 176,693 | 6/30/2023 |
| 2023 Q1 | 5/17/2024 | 48,727 | 0.1% | 154,654 | 3/31/2023 |
| 2022 Q4 | 5/17/2024 | 49,670 | 0.1% | 172,000 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 51,444 | 0.1% | 177,674 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 58,386 | 0.1% | 207,196 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 58,272 | 0.1% | 223,292 | 3/31/2022 |
| 2021 Q4 | 2/14/2022 | 45,331 | 0.1% | 203,786 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 42,131 | 0.1% | 232,272 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 58,342 | 0.1% | 289,359 | 6/30/2021 |
| 2021 Q1 | 5/17/2021 | 73,370 | 0.1% | 341,433 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 171,176 | 0.4% | 732,737 | 12/31/2020 |
| 2020 Q3 | 11/16/2020 | 563,406 | 1.4% | 2,070,434 | 9/30/2020 |
| 2020 Q2 | 8/14/2020 | 525,666 | 1.5% | 1,810,707 | 6/30/2020 |
| 2020 Q1 | 5/15/2020 | 394,606 | 1.3% | 1,658,360 | 3/31/2020 |
| 2019 Q4 | 3/12/2020 | 358,311 | 0.9% | 1,636,352 | 12/31/2019 |